Literature DB >> 10595757

The lymphomas.

V T DeVita1, G P Canellos.   

Abstract

The history of therapeutic advances in the lymphomas is reviewed. The initial studies that led to the cure of Hodgkin's disease and diffuse large B-cell lymphomas set a paradigm of cancer treatment broadly applicable to a number of malignancies. In recent times our knowledge of the biology of the Immune system has clarified the origin of subsets of lymphomas and provided specific targets of future therapeutic approaches.

Entities:  

Mesh:

Year:  1999        PMID: 10595757

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  4 in total

1.  Thomas Hodgkin: medical immortal and uncompromising idealist.

Authors:  Marvin J Stone
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

2.  FDG-PET/CT in re-staging of patients with lymphoma.

Authors:  L S Freudenberg; G Antoch; P Schütt; T Beyer; W Jentzen; S P Müller; R Görges; M R Nowrousian; A Bockisch; J F Debatin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11-26       Impact factor: 9.236

3.  Beyond "bad news": the diagnosis, prognosis and classification of lymphomas and lymphoma patients in the age of biomedicine (1945-1995).

Authors:  Peter Keating; Alberto Cambrosio
Journal:  Med Hist       Date:  2003-07       Impact factor: 1.419

Review 4.  Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs.

Authors:  Vanessa Innao; Vincenzo Rizzo; Andrea Gaetano Allegra; Caterina Musolino; Alessandro Allegra
Journal:  Curr Oncol       Date:  2020-12-25       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.